The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Female Health's revenues will grow 14.3% and EPS will grow 22.2%.
The average estimate for revenue is $9.9 million. On the bottom line, the average EPS estimate is $0.11.
Last quarter, Female Health booked revenue of $9.9 million. GAAP reported sales were 39% higher than the prior-year quarter's $7.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.29. GAAP EPS of $0.28 for Q4 were 75% higher than the prior-year quarter's $0.16 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 58.0%, 150 basis points worse than the prior-year quarter. Operating margin was 32.1%, 40 basis points worse than the prior-year quarter. Net margin was 82.6%, 1,910 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $37.4 million. The average EPS estimate is $0.52.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 304 members out of 313 rating the stock outperform, and nine members rating it underperform. Among 63 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 63 give Female Health a green thumbs-up, and give it a red thumbs-down.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Female Health. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Female Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.